FDA to Host Joint Meeting of Bone, Reproductive and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee

Summary

The US Food and Drug Administration (FDA) will convene a joint meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee to discuss various regulatory matters